| Lilit Arakelyan, | |
|
4744 Lankershim Blvd, North Hollywood, CA 91602-1833 | |
| (818) 505-0484 | |
| Not Available |
| Full Name | Lilit Arakelyan |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4744 Lankershim Blvd, North Hollywood, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164906319 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 79060 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lilit Arakelyan, 825 E San Jose Ave, Burbank, CA 91501-1317 Ph: (818) 599-9009 | Lilit Arakelyan, 4744 Lankershim Blvd, North Hollywood, CA 91602-1833 Ph: (818) 505-0484 |
News Archive
A recent study finds that COVID-19 alters the expression of several molecules involved in the homeostasis of blood pressure.
The Leukemia & Lymphoma Society together with the Lymphoma Research Foundation, CancerCare, the Association of Community Cancer Centers and Genentech announced the launch of a new partnership, the Alliance for Resource Collaboration in Hematology (ARCH).
In a research article published recently by the American Journal of Epidemiology, Oregon Research Institute (ORI) scientist Fuzhong Li, Ph.D., and colleagues show that a high-density of fast food outlets was associated with an increase of 3 pounds in weight and .8 inches in waist circumference among neighborhood residents who frequently ate at those restaurants.
In a new study that looked into post-operative death rates for one of the most common cancers, trends look worrying. On average 6.7% of patients died within a month of undergoing surgery for bowel cancer in England between 1998 and 2006. Patients face a seven-fold higher risk of dying after surgery in some NHS trusts than others, the study shows.
Progenics Pharmaceuticals, Inc. today announced the initiation of a phase 2 clinical trial of subcutaneous methylnaltrexone in Japan by its collaborator, Ono Pharmaceutical Co., Ltd. The drug, designated ONO-3849 in Japan, is being evaluated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness such as cancer.
› Verified 4 days ago
Avedis Kojayan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10945 Victory Blvd, North Hollywood, CA 91606 Phone: 818-487-0119 | |
Ladan Looyzadeh, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10955 Magnolia Blvd, North Hollywood, CA 91601 Phone: 818-760-3820 | |
Lily Kurumada, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5250 Lankershim Blvd, 9th Floor, North Hollywood, CA 91601 Phone: 818-508-2709 | |
Philip Ling-fat Kong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10945 Victory Blvd, North Hollywood, CA 91606 Phone: 818-487-0119 | |
Ashkhen Sinoryan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13021 Victory Blvd, North Hollywood, CA 91606 Phone: 818-760-2861 | |
Armenui Zargaryan, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11350 Victory Blvd, North Hollywood, CA 91606 Phone: 818-760-7300 | |
Tanya Moukhtarian, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4744 Lankershim Blvd, North Hollywood, CA 91602 Phone: 818-505-0484 |